News

court judge gavel business man bankruptcy lawsuit

The FTC argued that the $945M deal, first announced in 2024, was "anticompetitive." A federal judge agreed. 

Job candidate application

The latest federal jobs report brings good news to healthcare and social assistance, bad news to most other sectors.  

Thumbnail

Silintan is a dietary supplement marketed as a treatment for joint and body aches. According to a recent analysis by the FDA, however, all lots contained undeclared meloxicam, creating an increased risk of adverse events.

Nirat Beohar, MD, director, cardiac catheterization laboratory, medical director of the structural heart disease program, Mount Sinai Medical Center in Miami Beach, Florida, and a professor at the Columbia University Division of Cardiology, explains the financial landscape of the cath lab, what is ahead, and why cardiologists need to become more business savvy. #TCT

Financial literacy is no longer optional for physicians. “If you're not financially viable, you can't function,” explained Nirat Beohar, MD. “The business education is probably just as important as learning a new procedure.”

Thumbnail

These patients are typically treated with surgery, but those procedures carry their own risks that clinicians would prefer to avoid.

leg veins chronic venous disease PAD peripheral artery disease

The ACC and AHA have published updated performance and quality measures focused on the diagnosis and management of peripheral artery disease. Several other specialty societies, including SCAI and SIR, also participated in the development of this new document.

RSNA is looking for a replacement for Suhny Abbara, MD, who is now the editor-in-chief of its flagship journal.

Blue Cross Blue Shield Association BCBS

The new policy applies to all health plans across Pennsylvania, New York, West Virginia and Delaware, “removing financial barriers for essential breast cancer diagnostics.”

pain pills opioids

The UnitedHealth Group subsidiary has not admitted any wrongdoing but said it has improved protocols for monitoring controlled substances.

artificial intelligence AI in healthcare

Buzzworthy developments of the past few days.

artificial intelligence AI in healthcare

Is U.S. healthcare capable of achieving its own quadruple aim? Or is that ideal destined to remain a perpetual pursuit, always chased but never really caught?

Marsha Blackburn

Lawmakers led by Sen. Marsha Blackburn, R-Tenn., made their plea in a June letter to the head of the agency. 

Around the web

The FTC argued that the $945M deal, first announced in 2024, was "anticompetitive." A federal judge agreed.